Skip to main content
. 2020 Jul 15;13:2365–2374. doi: 10.2147/IDR.S259252

Table 2.

Antibiotic Resistance Profile of Organisms Isolated from UTI Infections

Antibiotics Disk
(No./Percent%)

Bacterial Isolates
FEP GM AN SAM SXT FM CN CRO LEV CZ IMI MEN PTZ OFX V
Klebsiella pneumoniae 21 24 43 30 1 60 81 2 54 4 42 2 30 16 26
(15.1%) (17.2%) (30.9%) (21.5%) (0.7%) (43.1%) (58.2%) (1.49%) (38.8%) (2.8%) (30.2%) (1.4%) (21.5%) (11.5%) (18.7%)
Staphylococcus aureus 3 2 0 1 19 5 0 6 2 14 0 0 2 2 9
(4.2%) (2.8%) 0 (1.4%) (27.1%) (7.1%) 0 (8.5%) (2.8%) (20%) 0 0 (2.8%) (2.8%) (12.8%)
Staphylococcus epidermidis 3 4 2 1 16 3 0 8 3 2 1 0 4 2 4
(5.7%) (7.6%) (3.8%) (1.9%) (30.7%) (5.7%) 0 (15.3%) (5.7%) (3.8%) (1.9%) 0 (7.6%) (3.8%) (7.6%)
Enterobacter spp. 3 8 4 1 1 6 1 10 0 5 0 3 0 1 0
(9.6%) (25.8%) (12.9%) (3.2%) (3.2%) (19.3%) (3.2%) (32.2%) 0 (16.1%) 0 (9.6%) 0 (3.2%) 0
Pseudomonas aeruginosa 19 18 24 12 34 34 2 24 4 12 5 15 12 14 0
(27.1%) (25.7%) (34.2%) (17.1%) (48.5%) (48.5%) (2.8%) (34.2%) (5.7%) (17.1%) (7.1%) (21.4%) (17.1%) (20%) 0
Escherichia coli 83 127 54 8 444 98 11 302 14 209 4 20 37 145 0
(9.9%) (15.2%) (6.4%) (0.9%) (53.3%) (11.7%) (1.3%) (36.2%) (1.6%) (25.1%) (0.4%) (2.4%) (4.4%) (17.4%) 0
Acinetobacter baumannii 10 16 20 2 21 20 3 16 2 16 1 16 3 8 1
(33.3%) (53.3%) (66.6%) (6.6%) (70%) (66.6%) (10%) (53.3%) (6.6%) (53.3%) (3.3%) (53.3%) (10%) (26.6%) (3.3%)
Staphylococcus saprophyticus 0 0 0 0 0 0 0 4 1 3 0 3 2 1 0
0 0 0 0 0 0 0 (30.7%) (7.6%) (23%) 0 (23%) (15.3%) (7.6%) 0

Abbreviations: FEP, cefepime; GM, gentamicin; AN, amikacin; SAM, sulbactam; SXT, trimethoprim-sulfamethoxazole; FM, nitrofurantoin; CN, cefotetan; CRO, ceftriaxone; LEV, levofloxacin; CZ, cefazolin; IMI, imipenem; MEN, meropenem; PTZ, piperacillin/tazobactam; OFX, ofloxacin; V, vancomycin.